Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice
about
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 centuryNicotinic Receptors: Role in Addiction and Other Disorders of the Brain.A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine MetabolismInhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymesImpact of tobacco smoking and smoking cessation on cardiovascular risk and disease.The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalystSmoking cessation intervention: an evidence-based approach.Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence.Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.Variation in CYP2A6 Activity and Personalized Medicine.Inhibition of human cytochromes P450 2A6 and 2A13 by flavonoids, acetylenic thiophenes and sesquiterpene lactones from Pluchea indica and Vernonia cinerea.Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.Effects of Vernonia cinerea Compounds on Drug-metabolizing Cytochrome P450s in Human Liver Microsomes.
P2860
Q22305613-0E589690-AA7F-4E37-8D12-6F39A40A49F0Q33635666-2957F0BF-24EC-4126-B026-554F2317115FQ33653805-0227AE8C-EA43-4716-AC3A-A61BB614E665Q36283969-EF8F0D17-7327-4C1E-89A1-16431E7DEF72Q36406310-862E8FA2-E3D2-4052-AC45-0B91230509C7Q37169244-91C4ADB1-6F2F-4B8C-ABF0-98C8CDB9B1C1Q37197102-0B040D08-2D9E-45AD-9A9B-D49A26468E98Q37422732-D1A13B47-CD85-4BCD-A5FE-2D172D9AC416Q37702733-6A35DBFE-DE52-433A-A410-7E7E8A145381Q38617975-4F8C8EAB-32AA-419B-B958-6B1A13BC1247Q38815352-A1E6149E-E446-4048-9749-35836CCE1420Q42148360-0A19123C-5EA3-49A2-896D-5D87C0DB8776Q47163198-96B35127-C166-41F2-9172-FE90A95DAF18Q47735887-0B7E28C5-7A20-434F-9353-D753D783BD0AQ48209111-146A8BC5-49EB-4D2F-B011-F350C8B2ABB4Q48217129-CAF71B21-20D5-49AD-9920-852227F71D6F
P2860
Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Selegiline is a mechanism-base ...... metabolism in humans and mice
@ast
Selegiline is a mechanism-base ...... metabolism in humans and mice
@en
Selegiline is a mechanism-base ...... metabolism in humans and mice
@nl
type
label
Selegiline is a mechanism-base ...... metabolism in humans and mice
@ast
Selegiline is a mechanism-base ...... metabolism in humans and mice
@en
Selegiline is a mechanism-base ...... metabolism in humans and mice
@nl
prefLabel
Selegiline is a mechanism-base ...... metabolism in humans and mice
@ast
Selegiline is a mechanism-base ...... metabolism in humans and mice
@en
Selegiline is a mechanism-base ...... metabolism in humans and mice
@nl
P356
P1476
Selegiline is a mechanism-base ...... metabolism in humans and mice
@en
P2093
Eric C K Siu
P304
P356
10.1124/JPET.107.133900
P407
P577
2007-12-07T00:00:00Z